Metropolitan Life Insurance Company (MetLife)’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,424
| Closed | -$748K | – | 1171 |
|
|
2024
Q1 | $748K | Sell |
3,424
-32
| -0.9% | -$7.05K | 0.03% | 391 |
|
|
2023
Q4 | $786K | Sell |
3,456
-210
| -6% | -$44.1K | 0.04% | 362 |
|
|
2023
Q3 | $737K | Sell |
3,666
-828
| -18% | -$175K | 0.04% | 354 |
|
|
2023
Q2 | $932K | Sell |
4,494
-119
| -3% | -$23.1K | 0.05% | 334 |
|
|
2023
Q1 | $909K | Sell |
4,613
-1,351
| -23% | -$278K | 0.05% | 338 |
|
|
2022
Q4 | $1.21M | Sell |
5,964
-183
| -3% | -$35.8K | 0.05% | 325 |
|
|
2022
Q3 | $1.08M | Sell |
6,147
-233
| -4% | -$47.7K | 0.05% | 338 |
|
|
2022
Q2 | $1.28M | Sell |
6,380
-187
| -3% | -$39.9K | 0.06% | 313 |
|
|
2022
Q1 | $1.49M | Sell |
6,567
-6,059
| -48% | -$1.42M | 0.05% | 319 |
|
|
2021
Q4 | $3.41M | Sell |
12,626
-609
| -5% | -$151K | 0.05% | 328 |
|
|
2021
Q3 | $3.2M | Sell |
13,235
-589
| -4% | -$148K | 0.05% | 327 |
|
|
2021
Q2 | $3.28M | Sell |
13,824
-521
| -4% | -$119K | 0.05% | 326 |
|
|
2021
Q1 | $3.14M | Sell |
14,345
-690
| -5% | -$138K | 0.05% | 337 |
|
|
2020
Q4 | $2.63M | Sell |
15,035
-788
| -5% | -$136K | 0.04% | 373 |
|
|
2020
Q3 | $2.56M | Sell |
15,823
-665
| -4% | -$105K | 0.04% | 346 |
|
|
2020
Q2 | $2.35M | Sell |
16,488
-911
| -5% | -$126K | 0.04% | 358 |
|
|
2020
Q1 | $1.89M | Sell |
17,399
-81
| -0.5% | -$11.7K | 0.04% | 409 |
|
|
2019
Q4 | $2.54M | Sell |
17,480
-102
| -0.6% | -$14.7K | 0.04% | 418 |
|
|
2019
Q3 | $2.54M | Sell |
17,582
-134
| -0.8% | -$19.6K | 0.04% | 387 |
|
|
2019
Q2 | $2.63M | Buy |
17,716
+1,065
| +6% | +$149K | 0.04% | 384 |
|
|
2019
Q1 | $2.19M | Sell |
16,651
-768
| -4% | -$94.6K | 0.04% | 446 |
|
|
2018
Q4 | $1.89M | Sell |
17,419
-57
| -0.3% | -$7.64K | 0.04% | 459 |
|
|
2018
Q3 | $2.61M | Sell |
17,476
-701
| -4% | -$107K | 0.04% | 382 |
|
|
2018
Q2 | $2.8M | Sell |
18,177
-120
| -0.7% | -$18.1K | 0.05% | 346 |
|
|
2018
Q1 | $2.54M | Buy |
18,297
+125
| +0.7% | +$18.4K | 0.04% | 401 |
|
|
2017
Q4 | $2.49M | Sell |
18,172
-37,907
| -68% | -$5.01M | 0.03% | 419 |
|
|
2017
Q3 | $7.27M | Sell |
56,079
-1,302
| -2% | -$174K | 0.05% | 353 |
|
|
2017
Q2 | $7.6M | Sell |
57,381
-3,694
| -6% | -$452K | 0.05% | 337 |
|
|
2017
Q1 | $7.53M | Sell |
61,075
-1,280
| -2% | -$152K | 0.05% | 356 |
|
|
2016
Q4 | $6.88M | Sell |
62,355
-941
| -1% | -$105K | 0.05% | 385 |
|
|
2016
Q3 | $7.48M | Sell |
63,296
-670
| -1% | -$78.9K | 0.05% | 331 |
|
|
2016
Q2 | $7.16M | Buy |
63,966
+519
| +0.8% | +$55.9K | 0.05% | 348 |
|
|
2016
Q1 | $6.38M | Sell |
63,447
-611
| -1% | -$58.6K | 0.05% | 392 |
|
|
2015
Q4 | $6.8M | Sell |
64,058
-1,732
| -3% | -$179K | 0.05% | 342 |
|
|
2015
Q3 | $6.13M | Sell |
65,790
-1,040
| -2% | -$108K | 0.04% | 402 |
|
|
2015
Q2 | $6.96M | Sell |
66,830
-994
| -1% | -$103K | 0.05% | 386 |
|
|
2015
Q1 | $7.35M | Buy |
67,824
+10,256
| +18% | +$1.05M | 0.05% | 360 |
|
|
2014
Q4 | $5.34M | Buy |
57,568
+155
| +0.3% | +$13.7K | 0.04% | 511 |
|
|
2014
Q3 | $5.02M | Sell |
57,413
-809
| -1% | -$73.1K | 0.04% | 508 |
|
|
2014
Q2 | $5.12M | Sell |
58,222
-5,710
| -9% | -$495K | 0.04% | 529 |
|
|
2014
Q1 | $5.39M | Sell |
63,932
-2,375
| -4% | -$189K | 0.04% | 497 |
|
|
2013
Q4 | $5.21M | Sell |
66,307
-4,414
| -6% | -$376K | 0.04% | 493 |
|
|
2013
Q3 | $6.02M | Sell |
70,721
-2,580
| -4% | -$217K | 0.05% | 413 |
|
|
2013
Q2 | $6.3M | Buy |
+73,301
| New | +$6.09M | 0.05% | 384 |
|
Other funds holding LH
Metropolitan Life Insurance Company (MetLife)'s LH Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Labcorp (LH) in Q2 2024, closing a stake of 3,424 shares — an estimated $748K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in LH in Q2 2013 and held it in 44 quarters. The position peaked at $7.6M in Q2 2017. 854 funds tracked by Wall St. Rank hold LH as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 3,424 Labcorp shares in Q2 2024, an estimated $748K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Labcorp in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Labcorp position peaked at $7.6M in Q2 2017.
- 854 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.